AARTI PHARMALABS LIMITED
FDA inspection history in Tarapur, India, 2020
- 1
- Form 483
Every document, by year
- Form 483
2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One Form 483, at Tarapur, India.
Cited most
Across all AARTI PHARMALABS LIMITED observations on file
- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete AARTI PHARMALABS LIMITED file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Tarapur, India
One Form 483 · 2020 · 4 observations
Latest: Form 483, Feb 20, 2020 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-02-20 | 483 Form 483 | Tarapur, India | 4 | $99 |
Investigators on these documents
FEI number 3005256484 · most recent document Feb 20, 2020
About AARTI PHARMALABS LIMITED
How many FDA Form 483s has AARTI PHARMALABS LIMITED received?
FDA Intel has 1 Form 483 on file for AARTI PHARMALABS LIMITED; the most recent is dated Feb 20, 2020.
When was AARTI PHARMALABS LIMITED last inspected by FDA?
The most recent FDA inspection document on file for AARTI PHARMALABS LIMITED is a Form 483 dated Feb 20, 2020, for the site in Tarapur, India.
What did FDA cite at AARTI PHARMALABS LIMITED?
The regulations cited most in the observations on file for AARTI PHARMALABS LIMITED are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.